N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease

scientific article published on 31 July 2013

N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JACC.2013.07.019
P698PubMed publication ID23916937
P5875ResearchGate publication ID255690955

P50authorEric BoersmaQ57288054
P2093author name stringAnnemien E van den Bosch
Jolien W Roos-Hesselink
Judith A A E Cuypers
Maarten Witsenburg
Jackie S McGhie
Petra Opić
Titia P E Ruys
Jannet A Eindhoven
P433issue13
P407language of work or nameEnglishQ1860
P304page(s)1203-1212
P577publication date2013-07-31
P1433published inJournal of the American College of CardiologyQ2984355
P1476titleN-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease
P478volume62

Reverse relations

cites work (P2860)
Q38968650Alkaline Phosphatase: A Biomarker of Cardiac Function in Pediatric Patients
Q43655956Association between N-terminal pro-brain natriuretic peptide and quality of life in adult patients with congenital heart disease
Q37307245B-type natriuretic peptide: powerful predictor of end-stage chronic heart failure in individuals with systolic dysfunction of the systemic right ventricle.
Q38324210BNP in children with congenital cardiac disease: is there now sufficient evidence for its routine use?
Q38603770Cardiac biomarkers in children with congenital heart disease
Q36073360Clinical effects of a standardized Chinese herbal remedy, Qili Qiangxin, as an adjuvant treatment in heart failure: systematic review and meta-analysis
Q38672312Common long-term complications of adult congenital heart disease: avoid falling in a H.E.A.P.
Q38825516Current Role of Blood and Urine Biomarkers in the Clinical Care of Adults with Congenital Heart Disease
Q39196071Design and Implementation of a Prospective Adult Congenital Heart Disease Biobank
Q92732020Exploring the Prognostic Value of Novel Markers in Adults With a Systemic Right Ventricle
Q44030613Heart failure in adult congenital heart disease
Q39005911Heart transplantation in adult congenital heart disease
Q40850072Matrix metalloproteinases as candidate biomarkers in adults with congenital heart disease
Q54445625N-terminal pro-B-type natriuretic peptide predicts cardiovascular complications in pregnant women with congenital heart disease.
Q37341787NT-proBNP and exercise capacity in adult patients with congenital heart disease and a prosthetic valve: a multicentre PROSTAVA study
Q39165884NT-proBNP as Marker of Ventricular Dilatation and Pulmonary Regurgitation After Surgical Correction of Tetralogy of Fallot: A MRI Validation Study.
Q48263163NT-proBNP predicts mortality in adults with transposition of the great arteries late after Mustard or Senning correction.
Q55439640Prognostic Value of Serial N-Terminal Pro-B-Type Natriuretic Peptide Measurements in Adults With Congenital Heart Disease.
Q48491567Quantitative assessment of systolic right ventricular function using myocardial deformation in patients with a systemic right ventricle
Q35785968Relation between E/e' ratio and NT-proBNP levels in elderly patients with symptomatic severe aortic stenosis
Q48233248Right ventricular function and N-terminal pro-brain natriuretic peptide levels in adult patients with simple dextro-transposition of the great arteries
Q48349829The change in NT-pro-BNP and post-PTMC echocardiography parameters in patients with mitral stenosis. A pilot study
Q38182858The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update.
Q37023891Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology
Q35939968Usefulness of insulin like growth factor 1 as a marker of heart failure in children and young adults after the Fontan palliation procedure
Q96133576Utility of biomarkers in adult Fontan patients with decompensated heart failure

Search more.